📣 VC round data is live. Check it out!
- Public Comps
- Symrise
Symrise Valuation Multiples
Discover Symrise's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Nitto Denko, Akzo Nobel, RPM International, Jordan Phosphates Mines and more.
Symrise Overview
About Symrise
Symrise is a global supplier of ingredients for fragrances and flavourings across the food, beverage, household products, and pharmaceutical industries. With an estimated 12% market share, it is the world’s fourth-largest supplier of fragrances and flavourings. The company was created after a 2003 merger of two companies that originated in 1874 and 1919. With more than 12,000 employees, Symrise produces 35,000 products sourced from 10,000 mostly natural raw materials such as vanilla, citrus, blossoms, and plant or animal materials for more than 6,000 customers.
Founded
2003
HQ

Employees
12.7K
Website
Sectors
Financials (LTM)
EV
$14B
Valuation Multiples
Start free trialSymrise Financials
Symrise reported last 12-month revenue of $6B and EBITDA of $1B.
In the same LTM period, Symrise generated $2B in gross profit, $1B in EBITDA, and $613M in net income.
Revenue (LTM)
Symrise P&L
In the most recent fiscal year, Symrise reported revenue of $6B and EBITDA of $1B.
Symrise is profitable as of last fiscal year, with gross margin of 38%, EBITDA margin of 22%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
Symrise Stock Performance
Symrise has current market cap of $13B, and enterprise value of $14B.
Market Cap Evolution
Symrise's stock price is $89.87.
Symrise share price decreased by 2.6% in the last 30 days, and by 12.6% in the last year.
Symrise has an EPS (earnings per share) of $4.27.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14B | $13B | -2.5% | -2.6% | 3.9% | -12.6% | $4.27 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSymrise Valuation Multiples
Symrise trades at 2.5x EV/Revenue multiple, and 11.5x EV/EBITDA.
EV / Revenue (LTM)
Symrise Financial Valuation Multiples
As of June 3, 2026, Symrise has market cap of $13B and EV of $14B.
Symrise has a P/E ratio of 20.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Symrise Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Symrise Margins & Growth Rates
Symrise grew revenue by 1% but EBITDA decreased by 0% in the last fiscal year.
In the most recent fiscal year, Symrise reported gross margin of 38%, EBITDA margin of 22%, and net margin of 10%.
Symrise Margins
Symrise Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Symrise Operational KPIs
Symrise's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Symrise's Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Symrise's Rule of X is 24% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Symrise Competitors
Symrise competitors include Nitto Denko, Akzo Nobel, RPM International, Jordan Phosphates Mines, Ambuja Cements, Ecopro, Solstice Advanced Materials, Westlake, Nippon Paint and Covestro.
Most Symrise public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.7x | 1.6x | 6.6x | 6.5x | |||
| 1.4x | 1.4x | 9.1x | 10.0x | |||
| 2.2x | 2.0x | 13.7x | 13.1x | |||
| 7.2x | - | 13.8x | - | |||
| 2.7x | 2.6x | 15.4x | 16.2x | |||
| 5.8x | - | 157.4x | - | |||
| 4.0x | 4.0x | 16.4x | 16.0x | |||
| 1.3x | 1.3x | 13.5x | 10.1x | |||
This data is available for Pro users. Sign up to see all Symrise competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Symrise
Symrise has acquired 10 companies to date.
Last acquisition by Symrise was on November 20th 2024. Symrise acquired Probi for $383M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Symrise
| Description | Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented probiotics. Its research relates to living microorganisms with scientific health benefits. The main fields of research are gut health, immune system and nutrient absorption, iron absorption, bone health and stress and recovery. It operates in Consumer Healthcare (CHC) and Functional Food (FF). The company operates in United States, Americas, excluding the United States , Sweden, EMEA, excluding Sweden, and APAC. The company's business is divided into three operating segments. These segments are based on a geographical division and consist of the regions Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia and the Pacific). | - | Cutech is an Italian biotechnology firm based in Trento developing in vitro skin and hair follicle models as alternatives to animal testing for cosmetics. The company's 3D reconstructed human epidermis and dermal equivalents evaluate irritation, corrosion, and efficacy of skincare formulations. Cutech supplies validated OECD-compliant models to brands in Europe and Asia, complying with EU REACH regulations. | ADF/IDF is a Springfield, Missouri-headquartered supplier of natural poultry ingredients for pet food, human food, and beverage applications. The companies produce dehydrated meats, fats, and functional proteins across flavor, nutrition, and texture categories from 11 manufacturing sites and two technical centers in North America. ADF/IDF serves pet food giants, snack producers, and supplement brands with mechanically separated poultry and spray-dried plasma products. | |
| HQ Country | |||||
| HQ City | Lund | Milwaukee, WI | Padua | Eugene, OR | |
| Deal Date | 20 Nov 2024 | 20 Nov 2020 | 6 May 2019 | 31 Jan 2019 | |
| Valuation | $383M | undisclosed | $10M | $900M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Symrise acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Investments by Symrise
Symrise has invested in 3 companies to date.
Latest investment by Symrise was on June 7th 2024. Symrise invested in EvodiaBio in their $7M Series A round (EV/Revenue multiple available to Pro users).
Latest Investments by Symrise
| Description | EvodiaBio is a Copenhagen-based bio-industrial company producing natural fragrance compounds for food and beverage applications. Founded in 2021, it engineers sustainable scents using fermentation of plant-based feedstocks. Located in the Capital Region of Denmark, EvodiaBio supplies flavor profiles mimicking tropical fruits and exotic notes to global manufacturers. | EvodiaBio is a Copenhagen-based bio-industrial company producing natural fragrance compounds for food and beverage applications. Founded in 2021, it engineers sustainable scents using fermentation of plant-based feedstocks. Located in the Capital Region of Denmark, EvodiaBio supplies flavor profiles mimicking tropical fruits and exotic notes to global manufacturers. | - | Phlur is a fragrance brand offering unisex scents composed of natural ingredients like Missing Person and Tangerine Boy from its operations in New York. The company sells direct-to-consumer online and through retailers, emphasizing refillable packaging and transparency in sourcing essential oils. | |
| HQ Country | |||||
| HQ City | Copenhagen | Copenhagen | New York City, NY | Austin, TX | |
| Deal Date | 7 Jun 2024 | 20 Dec 2022 | 25 Mar 2021 | 29 May 2019 | |
| Round | Series A | Seed | Series A | Series A | |
| Raised | $7M | $4M | $4M | $7M | |
| Investors | Ananke Ventures; Export and Investment Fund; Newtree Impact; Nordic Foodtech VC; PINC; Symrise; The March Group; Thia Ventures | Newtree Impact; Nordic Foodtech VC; PINC; Symrise; Thia Ventures | Ignite Growth Brands; Johnson & Johnson Innovation; Symrise | Belcorp Ventures; Next Coast Ventures; Symrise | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Symrise investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Symrise
| When was Symrise founded? | Symrise was founded in 2003. |
| Where is Symrise headquartered? | Symrise is headquartered in Germany. |
| How many employees does Symrise have? | As of today, Symrise has over 12K employees. |
| Is Symrise publicly listed? | Yes, Symrise is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Symrise? | Symrise trades under SY1 ticker. |
| When did Symrise go public? | Symrise went public in 2006. |
| Who are competitors of Symrise? | Symrise main competitors include Nitto Denko, Akzo Nobel, RPM International, Jordan Phosphates Mines, Ambuja Cements, Ecopro, Solstice Advanced Materials, Westlake, Nippon Paint, Covestro. |
| What is the current market cap of Symrise? | Symrise's current market cap is $13B. |
| What is the current revenue of Symrise? | Symrise's last 12 months revenue is $6B. |
| What is the current revenue growth of Symrise? | Symrise revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Symrise? | Current revenue multiple of Symrise is 2.5x. |
| What is the current EBITDA of Symrise? | Symrise's last 12 months EBITDA is $1B. |
| What is Symrise's EBITDA margin? | Symrise's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Symrise? | Current EBITDA multiple of Symrise is 11.5x. |
| What is the current FCF of Symrise? | Symrise's last 12 months FCF is $612M. |
| What is Symrise's FCF margin? | Symrise's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Symrise? | Current FCF multiple of Symrise is 23.6x. |
| How many companies Symrise has acquired to date? | As of June 2026, Symrise has acquired 10 companies. |
| What was the largest acquisition by Symrise? | $1B acquisition of DIANA S.A.S. on 13th April 2014 was the largest M&A Symrise has done to date. |
| What companies Symrise acquired? | Symrise acquired DIANA S.A.S., ADF/IDF, Renessenz, Pinova Holdings, Probi, Flavor Infusion, Cobell, Cutech, Citratus Fragrâncias Indûstria e Comércio, and Sensient (fragrances unit). |
| In how many companies Symrise has invested to date? | As of June 2026, Symrise has invested in 3 companies. |
| What was the last Symrise investment? | On 7th June 2024 Symrise invested in EvodiaBio, participating in a $7M Series A round, alongside Ananke Ventures, Export and Investment Fund, Newtree Impact, Nordic Foodtech VC, PINC, The March Group, and Thia Ventures. |
| In what companies Symrise invested in? | Symrise invested in EvodiaBio, Phlur, and Sunday2Sunday. |
See public comps similar to Symrise
Lists including Symrise
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.



